Cargando…

Atrial fibrillation and the use of oral bisphosphonates

BACKGROUND: Epidemiological studies investigating a possible association between bisphosphonates and atrial fibrillation (AF) have reported conflicting findings. The objective of our study was to determine whether exposure to oral nitrogen-containing bisphosphonates alendronate and risedronate are a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pazianas, Michael, Cooper, Cyrus, Wang, Yiting, Lange, Jeff L, Russell, R Graham G
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071350/ https://www.ncbi.nlm.nih.gov/pubmed/21479144 http://dx.doi.org/10.2147/TCRM.S17899

Ejemplares similares

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
por: Pazianas, Michael
Publicado: (2021)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: reply to Yarom and Elad
por: Pazianas, M., et al.
Publicado: (2008)

Bisphosphonates and risk of atrial fibrillation: a meta-analysis
por: Kim, Seo Young, et al.
Publicado: (2010)

Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study
por: Herrera, L., et al.
Publicado: (2015)

Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis
por: Grosso, Anthony, et al.
Publicado: (2009)

The Association between Treatment with Bisphosphonates and the Risk of Atrial Fibrillation: A Meta-Analysis of Observational Studies
por: Park, Ji-Hyun, et al.
Publicado: (2022)

The Use Of Oral Ranolazine To Convert New Or Paroxysmal Atrial Fibrillation: A Review Of Experience With Implications For Possible "Pill In The Pocket" Approach To Atrial Fibrillation
por: Murdock, David K, et al.
Publicado: (2009)

Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
por: Mak, Anselm, et al.
Publicado: (2009)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study
por: Erichsen, R, et al.
Publicado: (2011)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Oral bisphosphonates and colorectal cancer
por: Vogtmann, Emily, et al.
Publicado: (2017)

Atrial Fibrillation and Oral Health
por: Hassan, Amaar, et al.
Publicado: (2021)

Trend of Prevalence of Atrial Fibrillation and use of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation in South Korea (2002–2013)
por: Son, Mi Kyoung, et al.
Publicado: (2018)

Oral bisphosphonate use and lung cancer incidence among postmenopausal women
por: Tao, M H, et al.
Publicado: (2018)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation
por: Shin, Hong-Won, et al.
Publicado: (2012)

Determinants of Oral Bisphosphonate Use Beyond 5 Years
por: Izano, Monika A., et al.
Publicado: (2020)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

Characterization of patients with atrial fibrillation not treated with oral anticoagulants
por: Johansson, Cecilia, et al.
Publicado: (2014)

Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction
por: Edwards, Jodi D., et al.
Publicado: (2020)

Evidence‐Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation
por: Schaffer, Andrea L., et al.
Publicado: (2019)

An uncommon complication of atrial fibrillation
por: Mallouppas, Michael, et al.
Publicado: (2015)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Sex‐Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation
por: Palamaner Subash Shantha, Ghanshyam, et al.
Publicado: (2017)

The effectiveness of atrial fibrillation special clinic on oral anticoagulant use for high risk atrial fibrillation patients managed in the community
por: Lau, Ka Man, et al.
Publicado: (2023)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
por: Angeli, Fabio, et al.
Publicado: (2023)

Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit()
por: Semb, Anne Grete, et al.
Publicado: (2022)

Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer
por: Yasui, Taku, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks
por: Deitelzweig, Steve, et al.
Publicado: (2013)

Vitamin D and bisphosphonates therapies for osteoporosis are associated with different risks of atrial fibrillation in women: A nationwide population-based analysis
por: Yang, Hung-Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t2qtbqt0rmuviudhsgbcg200ji